Monday, July 15, 2019 11:00:20 PM
freebies, to answer that ADHC thought...
Just on doing a "speculative valuation" on what we know to be coming into ADHC, the valuation is far greater than .15 per share. I have not created/posted the valuation to explain in greater detail yet because I think I need to wait until more is released from ADHC in an 8-K or PR first. What has been learned so far is very powerful if everything is valid. So far things look very real and good. Let's see what's further released/filed from the company.
v/r
Sterling
Just on doing a "speculative valuation" on what we know to be coming into ADHC, the valuation is far greater than .15 per share. I have not created/posted the valuation to explain in greater detail yet because I think I need to wait until more is released from ADHC in an 8-K or PR first. What has been learned so far is very powerful if everything is valid. So far things look very real and good. Let's see what's further released/filed from the company.
v/r
Sterling
Exit Strategy & Etiquette Thoughts for a Stock
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128822531
I never give investing advice; only my beliefs for risks in a stock.
Recent ADHC News
- American Diversified Holdings Operating Division GlucoGuard Retains Global Contract Research Organization (CRO) to Begin Patient Studies as Required by the FDA • Newsfile • 04/01/2026 12:30:00 PM
- American Diversified Holdings Corporation (ADHC) Announces Internal Technology Initiative Within Universal Wellness AI Division • Newsfile • 01/06/2026 02:00:00 PM
- GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program • Newsfile • 11/25/2025 02:00:00 PM
- GlucoGuard Receives $43 Million Enterprise Valuation From Prominent CFA Led Harbinger Research • Newsfile • 11/04/2025 02:00:00 PM
- American Diversified Holdings Corporation Receives $5,000,000 (Five Million) Financing Commitment from an Institutional Investment Fund • Newsfile • 10/16/2025 01:00:00 PM
- GlucoGuard Receives Scope of Work (SOW) Proposal from Arete Bioscience for FDA Recommended Sleep Study • Newsfile • 10/14/2025 10:00:00 AM
